Results 131 to 140 of about 12,593 (182)

Antifibrotic Drugs Regulate the Expression of Epithelial Sodium Channels in the Lungs. [PDF]

Adv Respir Med
Ito T, Fujimoto H, Toda M, Fridman D'Alessandro V, D'Alessandro-Gabazza CN, Kogue Y, Tsuruga T, Okano T, Furuhashi K, Saiki H, Tomaru A, Gabazza EC, Yasuma T, Kobayashi T.   +13 more
europepmc   +1 more source

Inefficacy of dexamethasone and pirfenidone as comparators in the bleomycin-induced pulmonary fibrosis model in SD rats. [PDF]

Front Med (Lausanne)
Tukhovskaya EA, Palikova YA, Severyukhina MS, Ismailova AM, Palikov VA, Slashcheva GA, Borozdina NA, Mikhaylov ES, Kravchenko IN, Kazakov VA, Kazakova EN, Kalabina EA, Rasskazova EA, Shinelev MV, Sadovnikova ES, Perepechenova NF, Rykov VA, Ivanova KA, Kudriaeva AA, Globenko AA, Kolosov AS, Jain EA, Patsap OI, Ignatyuk MA, Belogurov AA, Murashev AN.   +25 more
europepmc   +1 more source

"Pirfenidone in post-COVID-19 pulmonary fibrosis (FIBRO-COVID): a phase 2 randomised clinical trial." G. Bermudo-Peloche, B. Del Rio, V. Vicens-Zygmunt, <i>et al</i>. <i>Eur Respir J</i> 2025; 65: 2402249. [PDF]

Eur Respir J
europepmc   +1 more source

Advances in pharmacotherapy for fibrotic interstitial lung disease. [PDF]

Med Rev (2021)
Feng X, Deng M, Miao J, Zheng Z, Hou G.
europepmc   +1 more source

Evaluation of the Antifibrotic and Functional Effects of Pirfenidone in an Experimental Frozen Shoulder Model. [PDF]

J Orthop Res
Astan S, Balta O, Gevrek F.
europepmc   +1 more source

Circulating Endotrophin Predicts Myocardial Fibrosis Burden and Is Sensitive to Antifibrotic Therapy. [PDF]

JACC Adv
Black N, Lewis G, Soltani F, Dodd S, Williams SG, Schelbert EB, Laursen C, Angeli E, Reese-Petersen AL, Karsdal M, Genovese F, Miller CA.   +11 more
europepmc   +1 more source

Kynurenine-AhR-SLC39A10-Zn²⁺ signaling reprograms macrophages and enhances pirfenidone efficacy in pulmonary fibrosis. [PDF]

Cell Commun Signal
Yue H, Dong R, He J, Zhang F, Fan Y, Dou X, Zhou Q, Li X, He L, Zhang S, Yu Q, Gu W, Zhao J, Wang Y, Wang CY, Zhang H.   +15 more
europepmc   +1 more source

A phase 1 pharmacokinetics study of deupirfenidone (LYT-100) in healthy older adults. [PDF]

ERJ Open Res
Maher TM, Chen MC, Korth CC, Elenko E, Harnett MD, Garg V, Graham CS.   +6 more
europepmc   +1 more source

Detorsion is not innocent: pirfenidone prevents contralateral ovarian damage following ovarian torsion. [PDF]

Naunyn Schmiedebergs Arch Pharmacol
Halici H, Karakoy Z, Yurdgulu EE, Ay YA, Cadirci E, Toktay E, Kavas B.   +6 more
europepmc   +1 more source

Disease Mechanisms and Therapeutic Advances in Idiopathic and Progressive Pulmonary Fibrosis: From Approved Drugs to Emerging Strategies. [PDF]

J Clin Med
Tirelli C, Muscato G, Alaimo C, Di Leo I, Mirijaj S, Pennisi F, Vancheri C, Mondoni M.   +7 more
europepmc   +1 more source